BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24098356)

  • 1. The roles of APOBEC3G complexes in the incorporation of APOBEC3G into HIV-1.
    Ma J; Li X; Xu J; Zhang Q; Liu Z; Jia P; Zhou J; Guo F; You X; Yu L; Zhao L; Jiang J; Cen S
    PLoS One; 2013; 8(10):e74892. PubMed ID: 24098356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cellular source for APOBEC3G's incorporation into HIV-1.
    Ma J; Li X; Xu J; Zhang Q; Liu Z; Jia P; Zhou J; Guo F; You X; Yu L; Zhao L; Jiang J; Cen S
    Retrovirology; 2011 Jan; 8():2. PubMed ID: 21211018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear Exclusion of the HIV-1 host defense factor APOBEC3G requires a novel cytoplasmic retention signal and is not dependent on RNA binding.
    Bennett RP; Presnyak V; Wedekind JE; Smith HC
    J Biol Chem; 2008 Mar; 283(12):7320-7. PubMed ID: 18165230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction of APOBEC3G with human immunodeficiency virus type 1 nucleocapsid inhibits tRNA3Lys annealing to viral RNA.
    Guo F; Cen S; Niu M; Yang Y; Gorelick RJ; Kleiman L
    J Virol; 2007 Oct; 81(20):11322-31. PubMed ID: 17670826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional analysis of the two cytidine deaminase domains in APOBEC3G.
    Li X; Ma J; Zhang Q; Zhou J; Yin X; Zhai C; You X; Yu L; Guo F; Zhao L; Li Z; Zeng Y; Cen S
    Virology; 2011 Jun; 414(2):130-6. PubMed ID: 21489586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encapsidation of APOBEC3G into HIV-1 virions involves lipid raft association and does not correlate with APOBEC3G oligomerization.
    Khan MA; Goila-Gaur R; Kao S; Miyagi E; Walker RC; Strebel K
    Retrovirology; 2009 Nov; 6():99. PubMed ID: 19886996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mov10 and APOBEC3G localization to processing bodies is not required for virion incorporation and antiviral activity.
    Izumi T; Burdick R; Shigemi M; Plisov S; Hu WS; Pathak VK
    J Virol; 2013 Oct; 87(20):11047-62. PubMed ID: 23926332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dimerization domain of HIV-1 viral infectivity factor Vif is required to block virion incorporation of APOBEC3G.
    Miller JH; Presnyak V; Smith HC
    Retrovirology; 2007 Nov; 4():81. PubMed ID: 18036235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOBEC3G: an intracellular centurion.
    Chiu YL; Greene WC
    Philos Trans R Soc Lond B Biol Sci; 2009 Mar; 364(1517):689-703. PubMed ID: 19008196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The level of APOBEC3G (hA3G)-related G-to-A mutations does not correlate with viral load in HIV type 1-infected individuals.
    Ulenga NK; Sarr AD; Hamel D; Sankale JL; Mboup S; Kanki PJ
    AIDS Res Hum Retroviruses; 2008 Oct; 24(10):1285-90. PubMed ID: 18851679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical fractionation and purification of high-molecular-mass APOBEC3G complexes.
    Chiu YL
    Methods Mol Biol; 2011; 718():185-206. PubMed ID: 21370050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOBEC-1 and AID are nucleo-cytoplasmic trafficking proteins but APOBEC3G cannot traffic.
    Bennett RP; Diner E; Sowden MP; Lees JA; Wedekind JE; Smith HC
    Biochem Biophys Res Commun; 2006 Nov; 350(1):214-9. PubMed ID: 16999936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOBEC3G subunits self-associate via the C-terminal deaminase domain.
    Bennett RP; Salter JD; Liu X; Wedekind JE; Smith HC
    J Biol Chem; 2008 Nov; 283(48):33329-36. PubMed ID: 18842592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APOBEC3G inhibits DNA strand transfer during HIV-1 reverse transcription.
    Li XY; Guo F; Zhang L; Kleiman L; Cen S
    J Biol Chem; 2007 Nov; 282(44):32065-74. PubMed ID: 17855362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumultuous relationship between the human immunodeficiency virus type 1 viral infectivity factor (Vif) and the human APOBEC-3G and APOBEC-3F restriction factors.
    Henriet S; Mercenne G; Bernacchi S; Paillart JC; Marquet R
    Microbiol Mol Biol Rev; 2009 Jun; 73(2):211-32. PubMed ID: 19487726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction between HIV-1 Gag and APOBEC3G.
    Cen S; Guo F; Niu M; Saadatmand J; Deflassieux J; Kleiman L
    J Biol Chem; 2004 Aug; 279(32):33177-84. PubMed ID: 15159405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanostructures of APOBEC3G support a hierarchical assembly model of high molecular mass ribonucleoprotein particles from dimeric subunits.
    Wedekind JE; Gillilan R; Janda A; Krucinska J; Salter JD; Bennett RP; Raina J; Smith HC
    J Biol Chem; 2006 Dec; 281(50):38122-6. PubMed ID: 17079235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human APOBEC3F incorporation into human immunodeficiency virus type 1 particles.
    Wang X; Li X; Ma J; Zhang L; Ma L; Mi Z; Zhou J; Guo F; Kleiman L; Cen S
    Virus Res; 2014 Oct; 191():30-8. PubMed ID: 25038404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Function analysis of sequences in human APOBEC3G involved in Vif-mediated degradation.
    Zhang L; Saadatmand J; Li X; Guo F; Niu M; Jiang J; Kleiman L; Cen S
    Virology; 2008 Jan; 370(1):113-21. PubMed ID: 17916373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human-APOBEC3G-dependent restriction of porcine endogenous retrovirus replication is mediated by cytidine deamination and inhibition of DNA strand transfer during reverse transcription.
    Jin SY; Choi HY; Kim HS; Jung YT
    Arch Virol; 2018 Jul; 163(7):1907-1914. PubMed ID: 29610985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.